Aiyla Pharmaceuticals Private Limited
Founded in 2020 and headquartered in Tamil Nadu, India.
2020 | Kanchipuram, Tamil Nadu (India) | Active
Aiyla Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 28.37%
- Profit Growth 107.80%
- Ebitda 125.63%
- Net Worth 44.57%
- Total Assets 82.56%
About Aiyla Pharmaceuticals
Aiyla Pharmaceuticals Private Limited (APPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 May 2020 (Four years and nine months 9 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Arthy Rajagopal, Esak Aaron, Madhu Sureshkumar, and Two other members serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52310TN2020PTC169768
- Company No.
033818
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Home Appliances
Healthcare
Who are the key members and board of directors at Aiyla Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arthy Rajagopal  | Director | 26-May-2020 | Current |
| Esak Aaron | Director | 26-May-2020 | Current |
| Madhu Sureshkumar | Director | 26-May-2020 | Current |
| Dharman Gomathi | Additional Director | 04-Sep-2021 | Current |
| Kamaraj Thilagavathi | Additional Director | 04-Sep-2021 | Current |
Financial Performance of Aiyla Pharmaceuticals.
Aiyla Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.37% increase. The company also saw a substantial improvement in profitability, with a 107.8% increase in profit. The company's net worth Soared by an impressive increase of 44.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aiyla Pharmaceuticals?
Unlock access to Aiyla Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Namvanam Natural Farming Private Limited
Arthy Rajagopal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aiyla Pharmaceuticals?
Aiyla Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aiyla Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aiyla Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Aiyla Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Aiyla Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Aiyla Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
- Director Appointment
Dharman Gomathi was appointed as a Additional Director was appointed as a Additional Director on 04 Sep 2021 & has been associated with this company since 3 years 6 months .
- Director Appointment
Kamaraj Thilagavathi was appointed as a Additional Director was appointed as a Additional Director on 04 Sep 2021 & has been associated with this company since 3 years 6 months .
- Director Appointment
Arthy Rajagopal was appointed as a Director was appointed as a Director on 26 May 2020 & has been associated with this company since 4 years 9 months .
- Director Appointment
Esak Aaron was appointed as a Director was appointed as a Director on 26 May 2020 & has been associated with this company since 4 years 9 months .
Frequently asked questions
What is the Incorporation or founding date of Aiyla Pharmaceuticals Private Limited?
Aiyla Pharmaceuticals Private Limited was incorporated on 26 May 2020.
What is authorized share capital and paid-up capital of Aiyla Pharmaceuticals Private Limited?
The authorized share capital of Aiyla Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Aiyla Pharmaceuticals Private Limited?
Currently 5 directors are associated with Aiyla Pharmaceuticals Private Limited.
- Arthy Rajagopal
- Esak Aaron
- Madhu Sureshkumar
- Dharman Gomathi
- Kamaraj Thilagavathi
What is the registered address of Aiyla Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Aiyla Pharmaceuticals Private Limited is No. 259, Mkn Road Alandur India, Saidapet, Tamil Nadu, 600016.
What is the corporate identification number (CIN) and company number of Aiyla Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Aiyla Pharmaceuticals Private Limited is U52310TN2020PTC169768 and the company number is 033818 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Aiyla Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Aiyla Pharmaceuticals Private Limited has risen by 28.37%.
What change has been observed in the net worth of Aiyla Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Aiyla Pharmaceuticals Private Limited has experienced an upsurge of 44.57%.
When was the last Balance Sheet of Aiyla Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Aiyla Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.